About
Contact & Profiles
Research Areas
- Atrial Fibrillation Management and Outcomes
- Injury Epidemiology and Prevention
- Poisoning and overdose treatments
- Neurogenetic and Muscular Disorders Research
- RNA regulation and disease
- Heparin-Induced Thrombocytopenia and Thrombosis
- Blood Coagulation and Thrombosis Mechanisms
- Restraint-Related Deaths
- Protein Degradation and Inhibitors
Regen BioPharma (United States)
2015
Columbia University
2014
10.1016/s0140-6736(15)00515-2
article
EN
The Lancet
2015-11-05
<h3>Objective:</h3> To quantify change in symptoms over time using home-based gait and mobility assessments from a prospective natural history study of patients with adrenomyeloneuropathy (AMN). <h3>Background:</h3> AMN is rare neurodegenerative disorder the brain spinal cord affecting adults mutations <i>ABCD1</i> gene. Quantification disease progression challenging, owing to phenotypic variability. One solution address this measure traditional functional motor tasks more frequently...
10.1212/wnl.0000000000201912
article
EN
Neurology
2023-04-25
Coming Soon ...